研究

Tanaka F, Yokomise H, Soejima T, Uramoto H, Yamanaka T, Nakagawa K, Yamamoto N, Nishimura Y, Niwa H, Okada M, Nakagawa T, Yamashita M.

Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer. Ann Thorac Surg.

Sasaki T, Seto T, Yamanaka T, Kunitake N, Shimizu J, Kodaira T, Nishio M, Kozuka T, Takahashi T, Harada H, Yoshimura N, Tsutsumi S, Kitajima H, Kataoka M, Ichinose Y, Nakagawa K, Nishimura Y, Yamamoto N, Nakanishi Y.

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.

Kumazaki Y, Ozawa S, Nakamura M, Kito S, Minemura T, Tachibana H, Nishio T, Ishikura S, Nishimura Y.

An end-to-end postal audit test to examine the coincidence between the imaging isocenter and treatment beam isocenter of the IGRT linac system for Japan Clinical Oncology Group (JCOG) clinical trials.

Doi H, Fujiwara M, Kitajima K, Tanooka M, Terada T, Noguchi K, Ishikura R, Kamikonya N, Yamakado K.

Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.

Doi H, Uemoto K, Masai N, Tatsumi D, Shiomi H, Oh RJ.

Definitive re-irradiation using intensity-modulated radiation therapy in cancers of the head and neck, focusing on rare tumors.

Tatebe H, Doi H, Ishikawa K, Kawakami H, Yokokawa M, Nakamatsu K, Kanamori S, Shibata T, Kitano M, Nishimura Y.

Two-step intensity-modulated radiation therapy for oropharyngeal cancer: initial clinical experience and validation of clinical staging.

Inada M, Monzen H, Matsumoto K, Tamura M, Minami T, Nakamatsu K, Nishimura Y.

A novel radiation-shielding undergarment using tungsten functional paper for patients with permanent prostate brachytherapy.

Tachibana I, Nishimura Y, Hanaoka K, Inada M, Fukuda K, Tatebe H, Ishikawa K, Nakamatsu K, Kanamori S, Hosono M.

Tumor Hypoxia Detected by 18F-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT).

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida, J.

Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Kubo K, Monzen H, Tamura M, Hirata M, Ishii K, Okada W, Nakahara R, Kishimoto S, Kawamorita R, Nishimura Y.

Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer.

Hirata M, Monzen H, Tamura M, Kubo K, Matsumoto K, Hanaoka K, Okumura M, Nishimura Y.

Impact of the Lok-bar for High-precision Radiotherapy with Tomotherapy.

Tamura M, Monzen H, Matsumoto K, Okumura M, Doi H, Nishimura Y.

Reduction of potential risk for skin toxicity in megavoltage radiotherapy using a novel rigid couch.

Tamura M, Monzen H, Matsumoto K, Kubo K, Otsuka M, Inada M, Doi H, Ishikawa K, Nakamatsu K, Sumida I, Mizuno H, Yoon DK, Nishimura Y.

Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer.

Otsuka M, Monzen H, Matsumoto K, Tamura M, Inada M, Kadoya N, Nishimura Y.

Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.

Kijima K, Monzen H, Matsumoto K, Tamura M, Nishimura Y.

The shielding ability of novel tungsten rubber against the electron beam for clinical use in radiation therapy.